Ashish Baldi
Overview
Explore the profile of Ashish Baldi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
392
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rimpi , Verma S, Pinky , Baldi A
Naunyn Schmiedebergs Arch Pharmacol
. 2025 Feb;
PMID: 39907781
The medical device industry has experienced a significant upsurge in the number, diversity, and complexity of devices over the last two decades. As the global demand for medical devices grows,...
2.
Kushwaha S, Ashawat M, Arora R, Baldi A
Curr Pharm Des
. 2025 Jan;
PMID: 39835563
Aim: The aim of the current study was to explore nano-formulation for effective neuroprotection by auranofin. Background: Currently, the treatment options for various CNS disorders, particularly neurodegenerative disorders, are greatly...
3.
Joshi C, Baldi A, Kumar N, Pradhan J
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Dec;
PMID: 39621088
Traditional drug discovery approach is based on one drug-one target, that is associated with very lengthy timelines, high costs and very low success rates. Network pharmacology (NP) is a novel...
4.
Kaur S, Gandhi A, Sandhu S, Baldi A
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Sep;
398(2):1145-1153.
PMID: 39259332
Medical devices play an essential role in the delivery of healthcare but its use is not entirely risk free. There are several instances where it causes mortality or morbidity among...
5.
Bajwa N, Singh P, Kumar S, Arya G, Baldi A
Ther Deliv
. 2024 Sep;
15(9):653-666.
PMID: 39225262
In this study, we aimed to prepare enteric encapsulated spheroids containing inclusion complex using quality by design approach. A Box-Behnken design was employed to determine effects of variables on selected...
6.
Kushawaha S, Ashawat M, Baldi A
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Jul;
397(12):10031-10047.
PMID: 38967827
Alzheimer's disease remains an unsolved neurological puzzle with no cure. Current therapies offer only symptomatic relief, hindered by limited uptake through the blood-brain barrier. Auranofin, an FDA-approved compound, exhibits potent...
7.
Kaur S, Gulati H, Baldi A
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Jun;
397(11):8477-8483.
PMID: 38878087
Hypertension, which stands as a leading global health challenge, demands a dynamic approach for its effective management. The traditional methods of managing hypertension, centered on periodic clinic visits for blood...
8.
Arora R, Baldi A
Curr Pharm Des
. 2024 Apr;
30(19):1459-1471.
PMID: 38616755
Neurological disorders impose a significant burden on individuals, leading to disabilities and a reduced quality of life. However, recent years have witnessed remarkable advancements in pharmaceutical interventions aimed at treating...
9.
Kushawaha S, Ashawat M, Soni D, Kumar P, Rimpi , Baldi A
Brain Res
. 2024 Apr;
1834:148906.
PMID: 38570152
Alzherimer's disease (AD) is an age-dependent ubiquitous ailment worldwide with limited therapies that only alleviate the symptoms of AD but do not cure them entirely because of the restricted blood-brain...
10.
Kumari M, Sharma S, Kanwar N, Naman S, Baldi A
Curr Drug Deliv
. 2024 Jan;
21(11):1474-1496.
PMID: 38243938
Respiratory disorders, such as tuberculosis, cystic fibrosis, chronic obstructive pulmonary disease, asthma, lung cancer, and pulmonary inflammation, are among the most prevalent ailments in today's world. Dextran, an exopolysaccharide formed...